Big Eye Diagnostics Inc.

San Diego, CA Big Eye Diagnostics

UEI
C3KTPAW1E1Z7
CAGE
94CB8
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
9909 Huennekens St STE 206, San Diego, CA 92121, USA
Website
bigeyedx.com
Founded
2022

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Big Eye Diagnostics Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Novel diagnostic biomarkers discovery and validation for malaria and select neglected tropical diseases sbir phase i Contract · 75N93025C00005 National Institute of Allergy and Infectious Diseases $299,986
An easy-to-use, low-cost triplex RDT for the simultaneous diagnosis of HBV, HCV, and HIV infection, compatible with… Contract · 75N93024C00025 National Institute of Allergy and Infectious Diseases $299,659
Supporting who lymphatic filariasis elimination programs: progressing a highly sensitive and specific rapid diagnostic… Grant · R44AI184015 National Institute of Allergy and Infectious Diseases $1,590,229
Supporting who onchocerciasis elimination programs: progressing a highly sensitive and ultra-specific rapid diagnostic… Grant · R44AI174495 National Institute of Allergy and Infectious Diseases $4,580,968
First-in-class, highly sensitive and specific rapid diagnostic test to detect paragonimus infections - project summary /… Grant · R43AI172459 National Institute of Allergy and Infectious Diseases $516,342

About Big Eye Diagnostics Inc.

Written by GovTribe AI ·

Big Eye Diagnostics Inc. is a for-profit corporate entity specializing in the development of rapid diagnostic tests (RDTs) for neglected tropical diseases, with a focus on innovative biomedical technologies. Registered in SAM.gov since August 2021 and classified as a small business manufacturer of goods, the company has demonstrated a strong commitment to creating point-of-care diagnostic solutions targeting complex infectious diseases in both low-and-middle-income countries and the United States.

Through federal contract awards, Big Eye Diagnostics Inc. has secured multiple Small Business Innovation Research (SBIR) contracts with the National Institute of Allergy and Infectious Diseases (NIAID). These contracts, which are set aside for small businesses, focus on developing advanced diagnostic technologies, specifically targeting multiplex rapid diagnostic tests. The company's recent contract work includes developing a low-cost triplex RDT capable of simultaneously detecting hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infection. These contracts are structured as firm fixed-price definitive contracts with award values around $299,000, demonstrating the company's ability to secure competitive federal funding for innovative diagnostic research.

The company's federal grant awards are similarly focused on developing highly sensitive and specific rapid diagnostic tests for neglected tropical diseases. Through project grants from NIAID's Allergy and Infectious Diseases Research program, Big Eye Diagnostics has pursued diagnostic test development for several critical diseases, including lymphatic filariasis, onchocerciasis, and Paragonimus infections. These grants, ranging from approximately $300,000 to $797,000, support the development of novel diagnostic biomarkers and lateral flow assays designed to meet World Health Organization target product profiles. The grants involve collaborative research with institutions like the University of the Philippines, Manila, and aim to create point-of-care tests that can improve clinical management and surveillance of these complex infectious diseases in resource-limited settings.

SBA capabilities narrative

From the vendor's SBA profile

Development and manufacturing of diagnostics.

Quick answers

What is Big Eye Diagnostics Inc.'s UEI?

Big Eye Diagnostics Inc.'s Unique Entity ID (UEI) in SAM.gov is C3KTPAW1E1Z7.

What is Big Eye Diagnostics Inc.'s CAGE code?

Big Eye Diagnostics Inc.'s CAGE code is 94CB8.

What is Big Eye Diagnostics Inc.'s primary NAICS code?

Big Eye Diagnostics Inc.'s primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).

Where is Big Eye Diagnostics Inc. located?

Big Eye Diagnostics Inc.'s physical address in SAM.gov is 9909 Huennekens St STE 206, San Diego, CA 92121, USA.

Is Big Eye Diagnostics Inc. registered in SAM.gov?

Yes. Big Eye Diagnostics Inc.'s SAM.gov registration is active through July 1, 2027.

What is Big Eye Diagnostics Inc.'s most recent federal award?

Big Eye Diagnostics Inc.'s most recent federal contract award is Novel diagnostic biomarkers discovery and validation for malaria and select neglected tropical diseases sbir phase i (75N93025C00005), from National Institute of Allergy and Infectious Diseases, on December 1, 2024.

On GovTribe

See Big Eye Diagnostics Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login